William Blair Comments on PTC Therapeutics, Inc.’s Q2 2024 Earnings (NASDAQ:PTCT)
PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) – William Blair raised their Q2 2024 EPS estimates for shares of PTC Therapeutics in a research report issued on Monday, May 20th. William Blair analyst S. Corwin now forecasts that the biopharmaceutical company will post earnings of ($0.67) per share for the quarter, up from their previous […]
More Stories
JPMorgan Chase & Co. Cuts Arch Capital Group (NASDAQ:ACGL) Price Target to $106.00
Arch Capital Group (NASDAQ:ACGL – Free Report) had its target price decreased by JPMorgan Chase & Co. from $110.00 to...
Natera (NASDAQ:NTRA) Price Target Raised to $180.00
Natera (NASDAQ:NTRA – Free Report) had its target price hoisted by Canaccord Genuity Group from $165.00 to $180.00 in a...
Tesla (NASDAQ:TSLA) Price Target Raised to $400.00
Tesla (NASDAQ:TSLA – Free Report) had its price target lifted by Canaccord Genuity Group from $298.00 to $400.00 in a...
Intapp’s (INTA) “Market Perform” Rating Reiterated at Raymond James
Raymond James restated their market perform rating on shares of Intapp (NASDAQ:INTA – Free Report) in a research report sent...
Citigroup Cuts Redfin (NASDAQ:RDFN) Price Target to $9.00
Redfin (NASDAQ:RDFN – Free Report) had its price target trimmed by Citigroup from $10.50 to $9.00 in a research note...
Mizuho Cuts Western Digital (NASDAQ:WDC) Price Target to $82.00
Western Digital (NASDAQ:WDC – Free Report) had its price target lowered by Mizuho from $90.00 to $82.00 in a research...